SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Biopharma Update on the Novel Coronavirus: April 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
April 2, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: April 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 1, 2020.
April 1, 2020
 · 
8 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: March 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
March 31, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: March 30
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2020.
March 30, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Martin Good / Shutterstock
Drug Development
WHO Initiates a Clinical Trial for Four Drugs in Fight Against COVID-19
The World Health Organization is launching a clinical trial in Norway and Spain to assess four of the most promising drugs in the fight against COVID-19, the disease caused by the novel coronavirus that has spread across the globe.
March 27, 2020
 · 
3 min read
 · 
Alex Keown
Drug Development
Clinical Catch-Up: March 23-27
Although some clinical trials are being slowed or halted, others are reporting out data. Here’s a look.
March 27, 2020
 · 
8 min read
 · 
Mark Terry
Drug Development
BMS, Merck and Pfizer Join List of Companies Pausing Some Clinical Trials During Pandemic
As COVID-19 continues to expand across the globe, more pharmaceutical companies are hitting the brakes on clinical trials as part of an effort to ease the burden on doctors and facilities needed to treat patients combating the disease.
March 27, 2020
 · 
3 min read
 · 
Alex Keown
Drug Development
Biopharma Industry News for March 27: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
March 27, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 26: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
March 26, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Industry News for March 25: Update on the Novel Coronavirus
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
March 25, 2020
 · 
7 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Drug Development
Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU
January 23, 2024
 · 
5 min read
Drug Development
Recce Pharmaceuticals Reports Positive Phase I/II Trial Results of RECCE® 327 for the Treatment of Diabetic Foot Infections
January 23, 2024
 · 
6 min read
Drug Development
IAMA Therapeutics Announces First Subject Dosed in Phase 1 Study of IAMA-6 for the Treatment of Autism and Epilepsy
January 23, 2024
 · 
2 min read
Drug Development
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
January 23, 2024
 · 
10 min read
Business
AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen® in Combination with AstraZeneca’s Imfinzi® for the Treatment of Late-Stage Pancreatic Cancer
January 22, 2024
 · 
5 min read
Drug Development
Strand Therapeutics Receives IND Clearance for Programmable mRNA Therapy STX-001 to Treat Solid Tumors
January 22, 2024
 · 
2 min read
Drug Development
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries
January 19, 2024
 · 
10 min read
Drug Development
ALK completes first part of phase 1 trial with peanut SLIT-tablet
January 18, 2024
 · 
3 min read
Drug Development
Inflammasome Therapeutics Announces First Patient Dosed in Phase I Diabetic Macular Edema Study of the Dual Inflammasome Inhibitor K8
January 18, 2024
 · 
4 min read
Drug Development
Panbela Announces Publication of Clinical Data Titled: Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
January 18, 2024
 · 
6 min read
Drug Development
Evommune Announces Initiation of a Phase 1 Trial of its MRGPRX2 Antagonist for the Treatment of Chronic Spontaneous Urticaria
January 18, 2024
 · 
3 min read
Drug Development
Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck
January 18, 2024
 · 
5 min read
Drug Development
PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
January 18, 2024
 · 
4 min read
Drug Development
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
January 17, 2024
 · 
5 min read
Drug Development
Pacylex Pharmaceuticals Reports Phase 1 Safety and Efficacy Results for Zelenirstat in Colorectal and other Cancers
January 17, 2024
 · 
5 min read
Drug Development
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research
January 17, 2024
 · 
5 min read
Drug Development
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
January 17, 2024
 · 
8 min read
Drug Development
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
January 17, 2024
 · 
5 min read
Drug Development
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
January 17, 2024
 · 
5 min read
Drug Development
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
January 16, 2024
 · 
7 min read
Load More